The global Hidradenitis Suppurativa (HS) market size was USD 727.4 million in 2022 and is expected to register a rapid revenue CAGR of 5.2% during the forecast period. Rising number of hidradenitis suppurativa cases across the globe and increasing awareness about hidradenitis suppurativa among both healthcare professionals and public and development of a diverse pipeline of potential treatments...